Form CERTNAS - Certification by the Nasdaq Stock Market approving securities for listing:
SEC Accession No. 9999999997-13-017230
Filing Date
2013-12-12
Accepted
2013-12-12 10:18:32
Documents
1
Effectiveness Date
2013-12-12

Document Format Files

Seq Description Document Type Size
1 AUTO-GENERATED PAPER DOCUMENT 9999999997-13-017230.paper CERTNAS 294
  Scanned paper document scanned.pdf   46581
  Complete submission text file 9999999997-13-017230.txt   1433
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 0331
Type: CERTNAS | Act: 34 | File No.: 001-36242 | Film No.: 13003691
SIC: 2834 Pharmaceutical Preparations